CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

41 API Suppliers, 10 USDMF, 6 CEP/COS, 7 JDMF, 2 EU WC, 5 KDMF, 2 NDC API, 25 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

56 Drugs in Development

56 Drugs in Development

INTERMEDIATES

5 Intermediate Suppliers

5 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

635 FDF Dossiers, 60 FDA Orange Book, 303 Europe, 3 Canada, 20 Australia, 88 South Africa, 161 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 200MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 400MG/200ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE, SUSPENSION;OTIC - 6% (60MG/ML), SUSPENSION/DROPS;OTIC - 0.3%;0.1%

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Rochem International Inc, 5 SPI Pharma, 7 DKSH, 10 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 7 Kirsch Pharma, 1 ACG Worldwide, 12 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 35 BASF, 1 BioSpectra, 1 Clariant, 11 Corel Pharma Chem, 6 DFE Pharma, 2 Esteem Industries, 2 Finar, 14 Gangwal Chemicals, 5 Ideal Cures, 4 Ingredion Pharma Solutions, 22 Kerry, 3 Keval Exports, 4 Kima Chemical, 6 Lonza Capsugel, 15 Microlex e.U, 2 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 4 Novo Excipients, 4 Pharmatrans-Sanaq, 8 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 30 Roquette, 13 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 11 Sigachi Industries, 4 Silverline Chemicals, 3 The Dow Chemical Company, 3 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

72 Fillers, Diluents & Binders, 52 Coating Systems & Additives, 40 Disintegrants & Superdisintegrants, 36 Thickeners and Stabilizers, 35 Granulation, 33 Direct Compression, 32 Solubilizers, 29 Parenteral, 28 Controlled & Modified Release, 23 Topical, 21 Lubricants & Glidants, 19 Film Formers & Plasticizers, 16 Taste Masking, 14 Co-Processed Excipients, 12 Chewable & Orodispersible Aids, 10 Emulsifying Agents, 7 API Stability Enhancers, 7 Rheology Modifiers, 5 Empty Capsules, 5 Surfactant & Foaming Agents, 5 Coloring Agents, 4 Vegetarian Capsules

DIGITAL CONTENT

59 News #PharmaBuzz

59 News #PharmaBuzz

GLOBAL SALES INFORMATION

11 US Medicaid Prescriptions, 226 Regulatory FDF Prices, 2 Annual Reports

MARKET PLACE

72 APIs, 38 FDF Dossiers

PATENTS & EXCLUSIVITIES

9 US Patents, 6 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 1 USP, 19 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 207986 / DOSAGE - INJECTABLE, SUSPENSION;OTIC - 6% (60MG/ML)

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
CIPROFLOXACIN(UNII: 5E8K9I0O4U) (CIPROFLOXACIN - UNII:5E8K9I0O4U)	CIPROFLOXACIN	6mg in 1

Inactive Ingredients

Ingredient Name	Otonomy, Inc.
HYDROCHLORIC ACID(QTT17582CB)
POLOXAMER 407(TUF2IVW3M2)
SODIUM CHLORIDE(451W47IQ8X)
TROMETHAMINE(023C2WHX2V)
WATER(059QF0KO0R)

Setid 8365e37a 0b35 497c Aab4 F25053378154 Applno 207986 Form Injectable Suspension Otic Dosage 6 60mg Ml - Drug Product Composition: CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER